Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03799120Phase 4Unknown

Daily Versus Twice Per Day Tamsulosin for Ureteral Stent Symptoms

Role: lead

NCT02619773Not ApplicableCompleted

Effect of Mupirocin Dressings Versus Island Dressings on Surgical Site Infections in Elective Colorectal Surgery

Role: lead

NCT01770236Phase 4Terminated

Pain Control After Minimally Invasive Coronary Artery Bypass Grafting

Role: lead

NCT00975377Not ApplicableCompleted

Clipping Versus No Hair Removal and the Risk of Surgical Site Infections

Role: lead

NCT01669850Not ApplicableTerminated

Clipped Versus Handsewn Arteriovenous Fistula Anastomosis

Role: lead

NCT00975013Completed

Bone Loss After Laparoscopic Roux-en-Y Gastric Bypass

Role: lead

NCT00971750Completed

Laparoscopic Versus Transabdominal Ultrasound in Morbidly Obese Patients

Role: lead

NCT01055574Terminated

Physical Capability Outcomes After Single-Level PD-L vs Single-Level ALIF: a Multi-Center Clinical Trial

Role: lead

NCT00797576Unknown

Detection of Left Atrial Appendage (LAA) Thrombus: Comparison of Cardiac Magnetic Resonance Imaging and Transesophageal Echocardiogram

Role: lead

All 9 trials loaded